Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SCM-004 1/30/03 2/12/03 DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SLR-002 7/8/02 7/9/02 Definity, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SLR-001 2/21/02 2/21/02 Definity (perflutren Lipid Microsphere) Injectable Suspension, DuPont Company NDA 21-064 7/31/01 05/08/03 11/1/01 Definity Indications: Use of activated Definity (perflutren Lipid Microsphere) Injectable Suspension in patients with suboptimal echocardiograms to opacity the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem Corp.